$25.42
Closed
-(-)

At close

Financial advisor consultation illustration
Get professional financial guidance

Schedule your free first call with a financial advisor on CUSP Wealth
*T&Cs apply

About

Azenta, Inc. is a global provider of life sciences solutions, enabling organizations worldwide to bring impactful breakthroughs and therapies to market faster. The company is headquartered in Burlington, Massachusetts and currently employs 3,000 full-time employees. The firm provides a full suite of cold-chain sample management solutions and multiomics services across areas such as drug development, clinical research and advanced cell therapies for pharmaceutical, biotech, academic and healthcare institutions globally. The firm's segments include Sample Management Solutions and Multiomics. Its Sample Management Solutions segment offers end-to-end sample management products and services, including sample repository services and core products (automated stores, cryogenic systems, automated sample tube, consumables and instruments and controlled rate thawing devices). The firm's Multiomics segment includes its genomic services business, which advances research and development activities by providing gene sequencing, synthesis, editing and related services. The firm's brands include GENEWIZ, FluidX, Ziath, 4titude, Limfinity, Freezer Pro, and Barkey.
Country

US

CEO

Mr. John Marotta

IPO date

1995

Employees

2,900

ISIN

US1143401024

Key stats

Open

$24.55

Volume

592.01K

Market cap

$1.17B

Prev. close

$25.42

Impl / hst vl

-

Open interest

$0.00

$24.45

Day’s Range

$25.56

$15.93

52W Range

$41.73

Valuation

61
Valuation score
Undervalued
P/E
-
P/S
1.94
P/B
0.75
Current ratio
2.83
Debt / Equity
-0.15
ROE
-10.69%
Gross margin
42.84%
Income growth
941.98%
FCF growth
-58.31

Dec

23

Dividends

The last payment date was Dec 23, 2021

Div. per Share

$0.10

Div. Yield

0.39%

Payout Ratio

23.28%

Div. Growth YoY

0.00%

Analysts estimates

Consensus rating
Buy

The average rating from top 6 analysts indicates that stock is expected to perform in line with the market

Str. Sell
Sell
Hold
Buy
Str. Buy
Avg. price target
$29.07
The top 8 analysts forecasts that 12-month price may increase by 14.36%, with a low of $20.20 and a high of $42.00
$20.20
Low
$29.07
Avg
$42.00
High
Current price

Earnings

Q1 ‘26 revenue
$144.80M
Q1 ‘26 net income
-$160.80M
Revenue
Net income
Previous EPS
-$0.04
Estimate EPS
$0.10
Actual EPS
Estimate EPS
Financial advisor consultation illustration
Get professional financial guidance

Schedule your free first call with a financial advisor on CUSP Wealth
*T&Cs apply